LetroMED 2.5 by Medi Pharma: strong aromatase inhibitor
Letrozole, sold as LetroMED 2.5 by Medi Pharma, is one of the most powerful oral aromatase inhibitors available. It dramatically reduces estrogen levels by reversibly blocking the aromatase enzyme, making it effective for treating existing gynecomastia and managing severe estrogenic side effects.
Key benefits
- Powerful estrogen reduction: The strongest AI available, capable of reducing estrogen by up to 98%.
- Treats existing gynecomastia: Effective for reversing early-stage gynecomastia symptoms.
- Eliminates water retention: Produces a very dry, vascular appearance.
- Post-cycle estrogen management: Useful during PCT to prevent estrogen rebound.
Potential side effects
- Severe joint pain: Dramatic estrogen reduction causes dry, painful joints.
- Loss of libido: Near-total estrogen suppression kills sex drive.
- Mood depression: Very low estrogen may affect emotional health.
- Bone density loss: Prolonged use weakens bones; short courses recommended.
Conclusion
LetroMED 2.5 by Medi Pharma is the strongest AI available, reserved for severe estrogen control. Low-dose protocol and careful monitoring prevent over-suppression.